Show simple item record

dc.contributor.authorReid, G.
dc.contributor.authorHiggs, Peter
dc.contributor.authorSharma, M.
dc.date.accessioned2017-01-30T13:56:38Z
dc.date.available2017-01-30T13:56:38Z
dc.date.created2014-10-14T00:55:08Z
dc.date.issued2014
dc.identifier.citationReid, G. and Sharma, M. and Higgs, P. 2014. The long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up. Journal of Public Health Research. 3 (1): 204 (6 p.).
dc.identifier.urihttp://hdl.handle.net/20.500.11937/36598
dc.identifier.doi10.4081/jphr.2014.204
dc.description.abstract

In South-East Asia Region (SEAR) there were an estimated 400, 000 - 500,000 people who inject drugs (PWID). HIV prevalence among PWID was commonly 20% and higher in Indonesia, Thailand, Myanmar, and some regions of India. Opioid substitution therapy (OST) has been implemented as an important HIV prevention intervention in the Region. Various key challenges and barriers to scale up of OST exist: pervasive stigma and discrimination towards PWID; crimilization of drug use overshadowing a public health response; lack of political will and national commitment; low financial investment; focus towards traditional treatment model of detoxification and rehabilitation; low dose of OST; and poor monitoring and evaluation of programmes.Local evidence has highlighted that OST can be successful within the Asian context. Such evidence should be utilized more widely to advocate for policy and increased political commitment to ensure OST reaches a substantial greater number of drug users than currently exists.

dc.publisherPAGEPress
dc.subjectIllicit drugs
dc.subjectMethadone
dc.subjectSoutheastern Asia
dc.subjectPolicy
dc.titleThe long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up
dc.typeJournal Article
dcterms.source.volume3
dcterms.source.issn2279-9036
dcterms.source.titleJournal of Public Health Research
curtin.note

This article is published under the Open Access publishing model and distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by-nc/3.0/ Please refer to the licence to obtain terms for any further reuse or distribution of this work.

curtin.departmentNational Drug Research Institute (Research Institute)
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record